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Background
Hydrogen sulfide (H2S) and nitric oxide (NO) have been
recognized as endogenous signaling molecules, involved in
a variety of homeostatic and disease processes. Although it
is well-established that NO increases cGMP content of
cells and tissues by activating soluble guanylyl cyclase
(sGC), the ability of H2S to affect cyclic nucleotides levels
has been controversial.
Results
We have shown that H2S increases cGMP in both
endothelial and smooth muscle cells. However, H2S
does not activate sGC or alter NO-induced sGC activity.
Interestingly, H2S inhibits phosphodiesterase (PDE) activ-
ity; although it reduces PDE activity of several PDE H2S is
most effective and potent against PDE-5. IN line with the
ability of H2S to increase cellular cGMP, we observed that
exposure of cells to H2S leads to activation of cGMP-
dependent protein kinase and VASP phosphorylation. As
both NO and H2S promote angiogenesis and vasodilation
we explored their interactions in the vessel wall in the
context of these two biological processes. Inhibition of
eNOS or PKG reduced the H2S-stumlated angiogenic
properties of endothelial cells, as well as H2S–stimulated
vasorelaxation, suggesting a prominent role for cGMP/
PKG pathways in H2S signaling. On the other hand, silen-
cing of the H2S-producing enzyme cystathionine-g-lyase
(CSE) reduced NO-stimulated cGMP accumulation,
angiogenesis and smooth muscle relaxation, proving that
NO requires H2S to manifest its effects. Finally, H2S-
induced wound healing and angiogenesis in vivo was sup-
pressed by pharmacological inhibition or genetic ablation
of eNOS.
Conclusion
Inhibition of the production of one gasotransmitter (NO
or H2S) reduces the ability of the other to elevate cGMP
and to trigger angiogenesis and vasodilation. These obser-
vations establish the existence of a positive, synergistic
cross-talk between H2S and NO in vascular tissues.
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